Publication: Induction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney Disease
Open/View Files
Date
2014
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Tampe, Björn, Desiree Tampe, Elisabeth M. Zeisberg, Gerhard A. Müller, Wibke Bechtel-Walz, Michael Koziolek, Raghu Kalluri, and Michael Zeisberg. 2014. “Induction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney Disease.” EBioMedicine 2 (1): 19-36. doi:10.1016/j.ebiom.2014.11.005. http://dx.doi.org/10.1016/j.ebiom.2014.11.005.
Research Data
Abstract
Progression of chronic kidney disease remains a principal problem in clinical nephrology and there is a pressing need for novel therapeutics and biomarkers. Aberrant promoter CpG island methylation and subsequent transcriptional silencing of specific genes have emerged as contributors to progression of chronic kidney disease. Here, we report that transcriptional silencing of the Ras-GTP suppressor RASAL1 contributes causally to progression of kidney fibrosis and we identified that circulating methylated RASAL1 promoter DNA fragments in peripheral blood correspond with levels of intrarenal levels of RASAL1 promoter methylation and degree of fibrosis in kidney biopsies, enabling non-invasive longitudinal analysis of intrarenal CpG island methylation.
Description
Other Available Sources
Keywords
Epigenetics, DNA methylation, Fibrosis, Ten-Eleven Translocation (TET), De-methylation, RASAL1
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service